| Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study A Norhammar, Å Tenerz, G Nilsson, A Hamsten, S Efendíc, L Rydén, ... The Lancet 359 (9324), 2140-2144, 2002 | 1614 | 2002 |
| Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term … K Malmberg, A Norhammar, H Wedel, L Ryden Circulation 99 (20), 2626-2632, 1999 | 1255 | 1999 |
| Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL study (comparative … M Kosiborod, MA Cavender, AZ Fu, JP Wilding, K Khunti, RW Holl, ... Circulation 136 (3), 249-259, 2017 | 728 | 2017 |
| Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction M Bartnik, K Malmberg, A Norhammar, A Tenerz, J Ohrvik, L Ryden European heart journal 25 (22), 1990-1997, 2004 | 474 | 2004 |
| Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL 2 study M Kosiborod, CSP Lam, S Kohsaka, DJ Kim, A Karasik, J Shaw, N Tangri, ... Journal of the American College of Cardiology 71 (23), 2628-2639, 2018 | 465 | 2018 |
| Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. AM Norhammar, L Rydén, K Malmberg Diabetes care 22 (11), 1827-1831, 1999 | 462 | 1999 |
| Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization A Norhammar, K Malmberg, E Diderholm, B Lagerqvist, B Lindahl, ... Journal of the American College of Cardiology 43 (4), 585-591, 2004 | 435 | 2004 |
| Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs … KI Birkeland, ME Jørgensen, B Carstensen, F Persson, HL Gulseth, ... The lancet Diabetes & endocrinology 5 (9), 709-717, 2017 | 376 | 2017 |
| Periodontitis increases the risk of a first myocardial infarction: a report from the PAROKRANK study L Rydén, K Buhlin, E Ekstrand, U de Faire, A Gustafsson, J Holmer, ... Circulation 133 (6), 576-583, 2016 | 335 | 2016 |
| Dapagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in people with type 2 diabetes (CVD‐REAL Nordic) when compared with dipeptidyl … F Persson, T Nyström, ME Jørgensen, B Carstensen, HL Gulseth, ... Diabetes, Obesity and Metabolism 20 (2), 344-351, 2018 | 268* | 2018 |
| The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: New features and the ‘Ten Commandments’ of the 2019 … PJ Grant, F Cosentino European heart journal 40 (39), 3215-3217, 2019 | 260* | 2019 |
| The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial LG Mellbin, K Malmberg, A Norhammar, H Wedel, L Ryden European heart journal 29 (2), 166-176, 2008 | 251 | 2008 |
| Abnormal glucose tolerance–a common risk factor in patients with acute myocardial infarction in comparison with population‐based controls M Bartnik, K Malmberg, A Hamsten, S Efendic, A Norhammar, A Silveira, ... Journal of internal medicine 256 (4), 288-297, 2004 | 200 | 2004 |
| Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetes A Tenerz, A Norhammar, A Silveira, A Hamsten, G Nilsson, L RYDen, ... Diabetes care 26 (10), 2770-2776, 2003 | 190 | 2003 |
| CVD-REAL Investigators and Study Group. Lower risk of heart failure and death in patients initiated on sodium-glucose cotransporter-2 inhibitors versus other glucose-lowering … M Kosiborod, MA Cavender, AZ Fu, JP Wilding, K Khunti, RW Holl, ... Circulation 136 (3), 249-59, 2017 | 183 | 2017 |
| Improved but still high short-and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of … A Norhammar, J Lindbäck, L Rydén, L Wallentin, U Stenestrand Heart 93 (12), 1577-1583, 2007 | 167 | 2007 |
| Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: a large multinational cohort study KI Birkeland, J Bodegard, JW Eriksson, A Norhammar, H Haller, ... Diabetes, obesity and metabolism 22 (9), 1607-1618, 2020 | 163 | 2020 |
| Under utilisation of evidence-based treatment partial explanation for the unfavourable prognosis in diabetic patients with acute myocardial infarction A Norhammar, K Malmberg, L Rydén, P Tornvall, U Stenestrand, ... European heart journal 24 (9), 838-844, 2003 | 161 | 2003 |
| Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden … A Norhammar, J Bodegård, T Nyström, M Thuresson, JW Eriksson, ... Diabetologia 59, 1692-1701, 2016 | 139 | 2016 |
| Type 2 diabetes and cardiovascular disease in women A Norhammar, K Schenck-Gustafsson Diabetologia 56, 1-9, 2013 | 139 | 2013 |
